Indole-3-carbinol and 3,3′-diindolylmethane induce expression of NAG-1 in a p53-independent manner

Biochemical and Biophysical Research Communications

Volumn 328, Issue 1, 2005, Pages 63-69

  Lee, Seong Ho ^a   Kim, Jong Sik ^b   Yamaguchi, Kiyoshi ^a   Eling, Thomas E ^b   Baek, Seung Joon ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Apoptosis; ATF3; DIM; GDF 15; I3C; NAG 1; p53

Indexed keywords

3 INDOLEMETHANOL; 3,3' DIINDOLYLMETHANE; ANTINEOPLASTIC AGENT; INDOLE DERIVATIVE; LUCIFERASE; PROTEIN P53; RESVERATROL; TRANSCRIPTION FACTOR IIIA; TRANSCRIPTION FACTOR IIIB; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL LINE; CELL PROLIFERATION; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GENE; GENE CONSTRUCT; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NONSTEROIDAL ANTI INFLAMMATORY DRUG ACTIVATED GENE 1; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INDUCTION; UPREGULATION;

ACTIVATING TRANSCRIPTION FACTOR 3; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; INDOLES; STILBENES; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 12844260806     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.12.138     Document Type: Article

References (45)

1. D.M. Parkin, P. Pisani, and J. Ferlay Global cancer statistics CA Cancer J. Clin. 49 1999 33 64
2. D.R. Jacobs Jr., L. Marquart, J. Slavin, and L.H. Kushi Whole-grain intake and cancer: an expanded review and meta-analysis Nutr. Cancer 30 1998 85 96
3. I. Chen, S. Safe, and L. Bjeldanes Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells Biochem. Pharmacol. 51 1996 1069 1076
4. D.J. Kim, D.H. Shin, B. Ahn, J.S. Kang, K.T. Nam, C.B. Park, C.K. Kim, J.T. Hong, Y.B. Kim, Y.W. Yun, D.D. Jang, and K.H. Yang Chemoprevention of colon cancer by Korean food plant components Mutat. Res. 523-524 2003 99 107
5. A. Oganesian, J.D. Hendricks, and D.E. Williams Long term dietary indole-3-carbinol inhibits diethylnitrosamine-initiated hepatocarcinogenesis in the infant mouse model Cancer Lett. 118 1997 87 94
6. M. Yoshida, S. Katashima, J. Ando, T. Tanaka, F. Uematsu, D. Nakae, and A. Maekawa Dietary indole-3-carbinol promotes endometrial adenocarcinoma development in rats initiated with N-ethyl-N′-nitro-N-nitrosoguanidine, with induction of cytochrome P450s in the liver and consequent modulation of estrogen metabolism Carcinogenesis 2004
7. B. Srivastava, and Y. Shukla Antitumour promoting activity of indole-3-carbinol in mouse skin carcinogenesis Cancer Lett. 134 1998 91 95
8. H.R. Frydoonfar, D.R. McGrath, and A.D. Spigelman Inhibition of proliferation of a colon cancer cell line by indole-3-carbinol Colorectal Dis. 4 2002 205 207
9. J. Zhang, B.A.J. Hsu, B.A.M. Kinseth, L.F. Bjeldanes, and G.L. Firestone Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells Cancer 98 2003 2511 2520
10. K.M. Rahman, Y. Li, and F.H. Sarkar Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells Nutr. Cancer 48 2004 84 94
11. T.D. Shultz, B.P. Chew, W.R. Seaman, and L.O. Luedecke Inhibitory effect of conjugated dienoic derivatives of linoleic acid and beta-carotene on the in vitro growth of human cancer cells Cancer Lett. 63 1992 125 133
12. Y.C. Chang, J. Riby, G.H. Chang, B.C. Peng, G. Firestone, and L.F. Bjeldanes Cytostatic and antiestrogenic effects of 2-(indol-3-ylmethyl)-3, 3′-diindolylmethane, a major in vivo product of dietary indole-3-carbinol Biochem. Pharmacol. 58 1999 825 834
13. C. Bonnesen, I.M. Eggleston, and J.D. Hayes Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines Cancer Res. 61 2001 6120 6130
14. C. Hong, H.A. Kim, G.L. Firestone, and L.F. Bjeldanes 3,3′-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression Carcinogenesis 23 2002 1297 1305
15. M. Nachshon-Kedmi, S. Yannai, A. Haj, and F.A. Fares Indole-3-carbinol and 3,3′-diindolylmethane induce apoptosis in human prostate cancer cells Food Chem. Toxicol. 41 2003 745 752
16. C.M. Cover, S.J. Hsieh, E.J. Cram, C. Hong, J.E. Riby, L.F. Bjeldanes, and G.L. Firestone Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells Cancer Res. 59 1999 1244 1251
17. C.M. Cover, S.J. Hsieh, S.H. Tran, G. Hallden, G.S. Kim, L.F. Bjeldanes, and G.L. Firestone Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling J. Biol. Chem. 273 1998 3838 3847
18. E.J. Cram, B.D. Liu, L.F. Bjeldanes, and G.L. Firestone Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter J. Biol. Chem. 276 2001 22332 22340
19. K.I. Jeon, J.K. Rih, H.J. Kim, Y.J. Lee, C.H. Cho, I.D. Goldberg, E.M. Rosen, and I. Bae Pretreatment of indole-3-carbinol augments TRAIL-induced apoptosis in a prostate cancer cell line, LNCaP FEBS Lett. 544 2003 246 251
20. S.J. Baek, K.S. Kim, J.B. Nixon, L.C. Wilson, and T.E. Eling Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities Mol. Pharmacol. 59 2001 901 908
21. M.R. Bootcov, A.R. Bauskin, S.M. Valenzuela, A.G. Moore, M. Bansal, X.Y. He, H.P. Zhang, M. Donnellan, S. Mahler, K. Pryor, B.J. Walsh, R.C. Nicholson, W.D. Fairlie, S.B. Por, J.M. Robbins, and S.N. Breit MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily Proc. Natl. Acad. Sci. USA 94 1997 11514 11519
22. P.X. Li, J. Wong, A. Ayed, D. Ngo, A.M. Brade, C. Arrowsmith, R.C. Austin, and H.J. Klamut Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression J. Biol. Chem. 275 2000 20127 20135
23. V.M. Paralkar, A.L. Vail, W.A. Grasser, T.A. Brown, H. Xu, S. Vukicevic, H.Z. Ke, H. Qi, T.A. Owen, and D.D. Thompson Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family J. Biol. Chem. 273 1998 13760 13767
24. M. Bottner, M. Laaff, B. Schechinger, G. Rappold, K. Unsicker, and C. Suter-Crazzolara Characterization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1) Gene 237 1999 105 111
25. R. Hromas, M. Hufford, J. Sutton, D. Xu, Y. Li, and L. Lu PLAB, a novel placental bone morphogenetic protein Biochim. Biophys. Acta 1354 1997 40 44
26. L.C. Wilson, S.J. Baek, A. Call, and T.E. Eling Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells Int. J. Cancer 105 2003 747 753
27. S.J. Baek, L.C. Wilson, and T.E. Eling Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53 Carcinogenesis 23 2002 425 434
28. S.J. Baek, J.S. Kim, J.B. Nixon, R.P. DiAugustine, and T.E. Eling Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1 J. Biol. Chem. 279 2004 6883 6892
29. K. Yamaguchi, S.H. Lee, T.E. Eling, and S.J. Baek Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of phosphatidylinositol 3-kinase/AKT/GSK-3beta pathway J. Biol. Chem. 279 2004 49617 49623
30. S.J. Baek, J.M. Horowitz, and T.E. Eling Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3 J. Biol. Chem. 276 2001 33384 33392
31. D. Newman, M. Sakaue, J.S. Koo, K.S. Kim, S.J. Baek, T. Eling, and A.M. Jetten Differential regulation of nonsteroidal anti-inflammatory drug-activated gene in normal human tracheobronchial epithelial and lung carcinoma cells by retinoids Mol. Pharmacol. 63 2003 557 564
32. K.S. Kim, S.J. Baek, G.P. Flake, C.D. Loftin, B.F. Calvo, and T.E. Eling Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue Gastroenterology 122 2002 1388 1398
33. K.S. Kim, J.H. Yoon, J.K. Kim, S.J. Baek, T.E. Eling, W.J. Lee, J.H. Ryu, J.G. Lee, J.H. Lee, and J.B. Yoo Cyclooxygenase inhibitors induce apoptosis in oral cavity cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene Biochem. Biophys. Res. Commun. 325 2004 1298 1303
34. S.J. Baek, J.S. Kim, F.R. Jackson, T.E. Eling, M.F. McEntee, and S.H. Lee Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells Carcinogenesis 25 2004 2425 2432
35. M. Tan, Y. Wang, K. Guan, and Y. Sun PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway Proc. Natl. Acad. Sci. USA 97 2000 109 114
36. S.R. Chinni, Y. Li, S. Upadhyay, P.K. Koppolu, and F.H. Sarkar Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells Oncogene 20 2001 2927 2936
37. X. Ge, F.A. Fares, and S. Yannai Induction of apoptosis in MCF-7 cells by indol-3-carbinol is independent of p53 and bax Anticancer Res. 19 1999 3199 3203
38. C.A. Bradfield, and L.F. Bjeldanes Structure-activity relationships of dietary indoles: a proposed mechanism of action as modifiers of xenobiotic metabolism J. Toxicol. Environ. Health 21 1987 311 323
39. S.J. Baek, L.C. Wilson, C.H. Lee, and T.E. Eling Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene J. Pharmacol. Exp. Ther. 301 2002 1126 1131
40. G. Brandi, M. Paiardini, B. Cervasi, C. Fiorucci, P. Filippone, C. De Marco, N. Zaffaroni, and M. Magnani A new indole-3-carbinol tetrameric derivative inhibits cyclin-dependent kinase 6 expression, and induces G1 cell cycle arrest in both estrogen-dependent and estrogen-independent breast cancer cell lines Cancer Res. 63 2003 4028 4036
41. X. Ge, S. Yannai, G. Rennert, N. Gruener, and F.A. Fares 3,3′-Diindolylmethane induces apoptosis in human cancer cells Biochem. Biophys. Res. Commun. 228 1996 153 158
42. T.W. Fawcett, J.L. Martindale, K.Z. Guyton, T. Hai, and N.J. Holbrook Complexes containing activating transcription factor (ATF)/cAMP-responsive- element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response Biochem. J. 339 Pt 1 1999 135 141
43. C. Yan, H. Wang, and D.D. Boyd ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter J. Biol. Chem. 277 2002 10804 10812
44. A. Monks, E. Harris, C. Hose, J. Connelly, and E.A. Sausville Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3- methylphenyl)-5-fluorobenzothiazole Mol. Pharmacol. 63 2003 766 772
45. M. Iizaka, Y. Furukawa, T. Tsunoda, H. Akashi, M. Ogawa, and Y. Nakamura Expression profile analysis of colon cancer cells in response to sulindac or aspirin Biochem. Biophys. Res. Commun. 292 2002 498 512